Shanghai Fengxian District Central Hospital
Shanghai Fengxian District Central Hospital
Explore linked clinical trials.3 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Study of SA+X in the Treatment of Newly Diagnosed AML | Hemic and Lymphatic Diseases, Neoplasms by Histologic Type, acute myeloid leukemia, hematologic disorder, leukemia, myeloid leukemia, neoplasm | Recruiting | Phase 2 | 2026-07-30 | NCT07548710 | |
| CGM for Insulin-Treated T2DM During Post-Discharge Transition | Nutritional and Metabolic Diseases, diabetes mellitus, endocrine system disorder, glucose metabolism disease, metabolic disease, type 2 diabetes mellitus | Recruiting | Not applicable | 2026-06-24 | NCT07414277 | |
| Precision Antithrombotic Therapy | Embolism and Thrombosis, Infarction, Necrosis, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Thromboembolism, brain disorder, cardiovascular disorder, central nervous system disorder, cerebrovascular disorder, heart disorder, ischemic disease, ischemic stroke, myocardial infarction, myocardial ischemia, nervous system disorder, stroke disorder, vascular disorder, venous thromboembolism | Enrolling by invitation | Not stated | 2026-06-17 | NCT07654634 |